Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Landscape and selection of vaccine epitopes in SARS-CoV-2
Christof C. Smith, Kelly Olsen, Kaylee M. Gentry, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2316-2331.e15
Open Access | Times Cited: 382
Computational identification of B and T-cell epitopes for designing a multi-epitope vaccine against SARS-CoV-2 spike glycoprotein
Truc Ly Nguyen, Thong Ba Nguyen, Heebal Kim
Journal of Structural Biology (2025), pp. 108177-108177
Closed Access | Times Cited: 1
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Yun-yu Zhang, Bi-ru Li, Bo-tao Ning
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 94
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 8
Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test development
Pavlo Holenya, Paul Joris Lange, Ulf Reimer, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1839-1849
Open Access | Times Cited: 54
Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach
Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 49
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein
Stefano A. Serapian, Filippo Marchetti, Alice Triveri, et al.
The Journal of Physical Chemistry Letters (2020) Vol. 11, Iss. 19, pp. 8084-8093
Open Access | Times Cited: 45
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern
Alice Triveri, Stefano A. Serapian, Filippo Marchetti, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4687-4700
Open Access | Times Cited: 33
T-Cell Epitope-Based Vaccines: A Promising Strategy for Prevention of Infectious Diseases
Xin Song, Yongfeng Li, Hongxia Wu, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1181-1181
Open Access | Times Cited: 4
Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
Valery A. Petrenko, James W. Gillespie, Laura M. De Plano, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 384-384
Open Access | Times Cited: 19
State of the Art in Epitope Mapping and Opportunities in COVID-19
Samira M. Hamed, Masarra M. Sakr, Ghadir S. El-Housseiny, et al.
Future Science OA (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
AlphaFold2 Reveals Structural Patterns of Seasonal Haplotype Diversification in SARS-CoV-2 Nucleocapsid Protein Variants
Muhammad Asif Ali, Gustavo Caetano‐Anollés
Viruses (2024) Vol. 16, Iss. 9, pp. 1358-1358
Open Access | Times Cited: 3
The role and uses of antibodies in COVID-19 infections: a living review
David Oliver Scourfield, Sophie Reed, Max Quastel, et al.
Oxford Open Immunology (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 25
Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins—A Possible Signature of Adaptive Selection
Arghavan Alisoltani, Lukasz Jaroszewski, Mallika Iyer, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 16
Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology
Charles Tiu, Feng Zhu, Lin‐Fa Wang, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 568-568
Open Access | Times Cited: 14
Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress
Angelina Kovalenko, Ekaterina M. Ryabchevskaya, Ekaterina A. Evtushenko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1701-1701
Open Access | Times Cited: 8
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants
Hao Zhou, Ping Leng, Yang Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 15, pp. 2456-2470
Closed Access | Times Cited: 2
Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries
Chunguang Liang, Elena Bencúrová, Eric Psota, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2630-2630
Open Access | Times Cited: 19
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2
Anna Foix, Daniel López, Francisco Díez‐Fuertes, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 2, pp. e1009726-e1009726
Open Access | Times Cited: 13
AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2
Giovanni Mazzocco, Iga Niemiec, Alexander Myronov, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 14
Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy
Yibeltal Akelew, Andualem Henok, Endris Ebrahim, et al.
Immunity Inflammation and Disease (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 14
Comprehensive Viral Genotyping Reveals Prognostic Viral Phylogenetic Groups in HPV16-Associated Squamous Cell Carcinoma of the Oropharynx
Travis P. Schrank, Lee Landess, Wesley H. Stepp, et al.
Molecular Cancer Research (2022) Vol. 20, Iss. 10, pp. 1489-1501
Open Access | Times Cited: 10
Immunoinformatic analysis of the whole proteome for vaccine design: An application to Clostridium perfringens
Luis F. Soto, Ana C. Romaní, Gabriel Jiménez-Avalos, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Aotus Monkeys for Human Use
Manuel E. Patarroyo, Manuel A. Patarroyo, Martha P. Alba, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top